---
schema_version: "secwatch.filing_event.v1"
accession: "0000021076-24-000027"
form_type: "8-K"
ticker: "CLX"
cik: "0000021076"
company_name: "CLOROX CO /DE/"
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T14:04:17.736136+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Clorox Q4 net sales -6% to $1.9B; adjusted EPS +9% to $1.82; divests VMS business

## Summary
- Q4 GAAP diluted EPS $1.73 (+22% YoY); adjusted EPS $1.82 (+9%) vs $1.67.
- Gross margin 46.5% (+380 bps) on lower costs; organic sales -3%.
- Announces sale of Better Health VMS business to Piping Rock Health Products; no deal value disclosed.
- FY24 free cash flow $483M vs $930M; net cash from ops $695M.
- FY25 outlook: expects return to volume growth consistent with long-term goals.

## SEC filing metadata
- accession: 0000021076-24-000027
- form_type: 8-K
- ticker: CLX
- cik: 0000021076
- company_name: CLOROX CO /DE/
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21076/000002107624000027/0000021076-24-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21076/000002107624000027/clx-20240801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000021076-24-000027
- JSON: https://secwatch.observer/filing/0000021076-24-000027.json
- Plain text: https://secwatch.observer/filing/0000021076-24-000027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.